cilengitide has been researched along with paxilline in 1 studies
| Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (paxilline) | Trials (paxilline) | Recent Studies (post-2010) (paxilline) |
|---|---|---|---|---|---|
| 194 | 29 | 133 | 2,097 | 3 | 790 |
| Protein | Taxonomy | cilengitide (IC50) | paxilline (IC50) |
|---|---|---|---|
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 33.55 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 5 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | Homo sapiens (human) | 5 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | Homo sapiens (human) | 5 | |
| BZLF2 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | 2.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodman, SL; Patsenker, E; Popov, Y; Schuppan, D; Wiesner, M | 1 |
1 other study(ies) available for cilengitide and paxilline
| Article | Year |
|---|---|
Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro.
Topics: Animals; Becaplermin; Cell Adhesion; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Focal Adhesion Kinase 1; Gene Expression Regulation; Hepatocytes; Humans; Integrin alphaVbeta3; Liver; Male; Paxillin; Peptides, Cyclic; Phosphoproteins; Platelet-Derived Growth Factor; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Snake Venoms | 2007 |